UP!

IMPR $19.26

IMPR target price
19.26
0
0

Imprivata is an IT security company based in Lexington, Massachusetts. Founded in 2002, Imprivata develops and sells the OneSign Platform for securing employee access to desktops, networks and applications using a single sign-on.

In 2011, Imprivata had over 1,250 clients and several offices. Imprivata customers are primarily from the healthcare industries. Imprivata became a public company on June 25, 2014, and was listed on the New York Stock Exchange, until it was acquired by private equity investment firm Thoma Bravo, LLC in 2016.

Imprivata was founded by Phil Scarfo and David Ting, who had developed identity management technology while working at Polaroid Corporation’s small business incubator.

The company shipped its first product, the OneSign Enterprise Single Sign-On appliance, in 2004. In 2005, Imprivata expanded to Europe, Africa and the Middle East, and in 2006 Imprivata founder David Ting was selected by InfoWorld as one of the top 25 chief technology officers of the year.

In 2009, Imprivata acquired the assets of IdentiPHI, a manufacturer and reseller of biometric technology, including the SAFsolution product line, and in 2011, acquired assets of Validus Medical Systems of Santa Cruz, California, which was incorporated into the Imprivata Cortext technology.

In July, 2016, Imprivata announced that it agreed to be acquired by Thoma Bravo, a private equity firm based in San Francisco, for $19.25, estimated at a total of $544 million. Omar Hussain was chief executive at the time.

Imprivata OneSign helps companies manage user access and authentication. Product reviews suggest that the OneSign allows companies to enable all enterprise applications for single sign on without requiring custom scripting or modifications to existing directories. OneSign can also strengthen user authentication to desktops and networks by replacing passwords with a range of authentication options that include finger biometrics, proximity cards, smart cards, many national and government ID cards, One-Time-Password tokens, and an employee’s physical location. Product reviews also comment on OneSign's ability to simplify compliance reporting by consolidating the employee strong authentication and application access events in a single database.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-13 Downgrade Piper Jaffray Cos. Overweight to Neutral
2016-06-24 Reiterated Rating Leerink Swann Outperform
2016-05-31 Reiterated Rating Oppenheimer Buy $16.00
2016-05-31 Reiterated Rating Oppenheimer Holdings Inc. Buy $16.00
2016-05-04 Boost Price Target Leerink Swann Outperform $13.00 to $16.00
2016-05-04 Reiterated Rating JPMorgan Chase & Co. Hold $17.00
2016-02-17 Lower Price Target Piper Jaffray Overweight $19.00 to $18.00
2016-02-17 Lower Price Target Leerink Swann Outperform $17.00 to $13.00
2016-02-17 Lower Price Target JPMorgan Chase & Co. Neutral $19.00 to $17.00
2016-02-17 Lower Price Target Barclays Overweight $15.00 to $14.00
2016-02-17 Lower Price Target Oppenheimer Outperform $17.00 to $16.00
2016-02-17 Lower Price Target Piper Jaffray Cos. Overweight $19.00 to $18.00
2016-02-17 Lower Price Target Barclays PLC Overweight $15.00 to $14.00
2015-11-13 Reiterated Rating Piper Jaffray Overweight $19.00
2015-11-03 Lower Price Target Oppenheimer Outperform $20.00 to $17.00
2015-11-03 Lower Price Target Topeka Capital Markets Buy $20.00 to $17.00
2015-11-03 Lower Price Target Piper Jaffray Buy $23.00 to $19.00
2015-11-03 Lower Price Target Leerink Swann Outperform $20.00 to $17.00
2015-11-03 Lower Price Target Barclays Overweight $22.00 to $15.00
2015-10-15 Reiterated Rating Piper Jaffray Buy
2015-10-15 Reiterated Rating Leerink Swann Buy $23.00 to $20.00
2015-10-15 Lower Price Target Barclays Overweight $28.00 to $22.00
2015-10-15 Lower Price Target Topeka Capital Markets Buy $24.00 to $20.00
2015-10-15 Downgrade William Blair Outperform to Market Perform
2015-10-15 Lower Price Target Stifel Nicolaus Buy $24.00 to $20.00
2015-10-15 Downgrade JPMorgan Chase & Co. Overweight to Neutral $24.00 to $19.00
2015-09-18 Boost Price Target Topeka Capital Markets Buy $21.00 to $24.00
2015-08-17 Initiated Coverage JPMorgan Chase & Co. Overweight $24.00
2015-08-17 Initiated Coverage Barclays Overweight $28.00
2015-08-17 Initiated Coverage Stifel Nicolaus Buy $24.00
2015-07-08 Initiated Coverage Topeka Capital Markets Buy $21.00
2015-06-18 Reiterated Rating Stephens Outperform $20.00
2015-06-17 Initiated Coverage Oppenheimer Outperform $20.00
2015-05-26 Boost Price Target JPMorgan Chase & Co. Overweight $17.00 to $20.00
2015-05-09 Reiterated Rating Leerink Swann Outperform $21.00 to $23.00
2015-01-08 Lower Price Target JPMorgan Chase & Co. Overweight $19.00 to $17.00
2014-10-27 Initiated Coverage Leerink Swann Outperform $18.00
2014-07-21 Initiated Coverage Wells Fargo & Co. Outperform
2014-07-21 Initiated Coverage William Blair Outperform
2014-07-21 Initiated Coverage JPMorgan Chase & Co. Overweight $19.00
2014-07-21 Initiated Coverage Piper Jaffray Overweight $20.00
2014-07-21 Initiated Coverage Wells Fargo Outperform
2016-07-13 Downgrade Piper Jaffray Cos. Overweight to Neutral
2016-06-24 Reiterated Rating Leerink Swann Outperform
2016-05-31 Reiterated Rating Oppenheimer Buy $16.00
2016-05-31 Reiterated Rating Oppenheimer Holdings Inc. Buy $16.00
2016-05-04 Boost Price Target Leerink Swann Outperform $13.00 to $16.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In IMPR 0 funds of 2213 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
Ting David Chief Technology Officer 1.72%  (408103) IMPR /
Shaw Christopher A SVP and General Manager 0.92%  (218844) IMPR /
Kalowski Jeffrey Chief Financial Officer 0.88%  (209441) IMPR /
Hussain Omar President and CEO 0.68%  (162678) IMPR /
Brigiotta Thomas W. SVP, WW Sales and Field Ops 0.56%  (132787) IMPR /
BLAESER JOHN A 0.44%  (104582) IMPR /
Orfao David J 0.38%  (91388) BCOV / IMPR /
General Catalyst Group II, L.P. 0.38%  (89716) IMPR /
Highland Management Partners VI, Inc. 0.37%  (86724) IMPR /
Weismann Rodger 0.32%  (75101) IMPR /
POLARIS VENTURE MANAGEMENT CO III LLC 0.18%  (42002) IMPR /
BARRETT DAVID E 0.18%  (42002) IMPR /
MAEDER PAUL A 0.02%  (5818) IMPR / TWOU /
HALAMKA JOHN MD MS 0.02%  (5102) IMPR /